Fentanyl 0.05 MG/ML Injection — RxCUI 1735004
RxNorm drug concept · Semantic clinical drug
RxCUI 1735004
Semantic clinical drug · SCD
Retired or remapped concept 1 FDA product
5 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1735004
Official nameFentanyl 0.05 MG/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusRetired or remapped concept
FDA products mapped1
Package NDCs mapped5
Reported Medicaid activity (SDUD)235,840 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Fentanyl: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It depends on the form. The patch treats severe, ongoing pain in people already used to opioids. The lozenge treats breakthrough cancer pain, and the injection is used by anesthesi...
- No. The patch and lozenge are only for people who are already opioid-tolerant. In someone who isn't, they can cause dangerous or fatal slowed breathing.
- Can I use fentanyl if I've never taken opioids?
- Please don't without checking with me or your doctor. Alcohol, benzodiazepines and other sedating medicines can cause profound sleepiness, slowed breathing and death.
🕸️ Concept Web
No related-concept groups were available for this RxCUI in the loaded RxNorm data. That does not prove that no related concepts exist.
📦 FDA Products & Package NDCs
1 product · 5 package NDCs
5 package NDCs map to RxCUI 1735004 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00409-9094-22 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-22) / 2 mL in 1 V... | Fentanyl Citrate | Hospira, Inc. | 2010-12-02 |
| 00409-9094-25 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-25) / 5 mL in 1 V... | Fentanyl Citrate | Hospira, Inc. | 2005-11-09 |
| 00409-9094-28 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-28) / 10 mL in 1... | Fentanyl Citrate | Hospira, Inc. | 2006-02-17 |
| 00409-9094-31 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9094-31) / 20 mL in 1... | Fentanyl Citrate | Hospira, Inc. | 2005-09-27 |
| 00409-9094-61 | 25 CARTON in 1 TRAY (0409-9094-61) / 1 VIAL, SINGLE-DOSE in... | Fentanyl Citrate | Hospira, Inc. | 2005-12-22 |
Observed labelers:
Hospira, Inc. (5)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$1.4191
Range $1.4191–$1.4191
· middle 50% $1.4191–$1.4191
· 1 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J3010 | Fentanyl citrate injection | 5 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.